EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Combination of anti-TNFα therapy and surgical resection for severe chronic intestinal rejection: A case report

Katrina Tan, Elizabeth Low, Graham Starkey, Khashayar Asadi, Adam Testro, Darren Wong

Intestinal Failure · 2024

DOI: 10.1016/j.intf.2024.100025 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Intestinal Failure, 2024. Verfasst von Katrina Tan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Australian Intestinal Transplant Service, Austin Health, Australia. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Acute cellular rejection (ACR) is a well-recognised cause of graft failure in intestinal transplant (ITx) recipients. Management of ACR is with intravenous (IV) steroids, increased immunosuppression and T-cell depleting therapies. Use of alternative therapies such as anti-tumour necrosis factor alpha (TNFα) agents in steroid-refractory cases should be considered. Case report: A 44-year-old male who received a combined liver-intestinal transplant with ACR unresponsive to IV steroids and anti-thymocyte globulin (ATG), which evolved into chronic rejection (CR). His symptoms were predominantly obstructive with endoscopic similarities to stricturing Crohn's disease. He was successfully managed with infliximab followed by segmental graft resection. With ongoing maintenance infliximab he has remained clinically well with enteral autonomy and no recurrence of rejection.

Conclusion

Alternative therapies for management of severe ACR unresponsive to traditional management should be considered in ITx patients. There are increasing numbers of case reports to support the use of anti-TNFα therapy in these cases.

Schlagwörter

Stichwörter der Autor:innen

Acute cellular rejectionChronic rejectionInfliximabIntestinal transplant

Autor:innen und Institutionen

  • Australian Intestinal Transplant Service, Austin Health, Australia.
  • Australian Centre for Transplant Excellence and Research, Australia.
  • Department of Medicine, University of Melbourne, Australia.

Zitieren

APA

Tan, K., Low, E., Starkey, G., Asadi, K., Testro, A., & Wong, D. (2024). Combination of anti-TNFα therapy and surgical resection for severe chronic intestinal rejection: A case report. Intestinal Failure. https://doi.org/10.1016/j.intf.2024.100025

Vancouver

Tan K, Low E, Starkey G, Asadi K, Testro A, Wong D. Combination of anti-TNFα therapy and surgical resection for severe chronic intestinal rejection: A case report. Intestinal Failure. 2024. doi:10.1016/j.intf.2024.100025

BibTeX
@article{Tan2024,
  author = {Tan, Katrina and Low, Elizabeth and Starkey, Graham and Asadi, Khashayar and Testro, Adam and Wong, Darren},
  title = {Combination of anti-TNFα therapy and surgical resection for severe chronic intestinal rejection: A case report},
  journal = {Intestinal Failure},
  year = {2024},
  doi = {10.1016/j.intf.2024.100025}
}
Kostenlos starten →